The landscape of dementia diagnosis has developed substantially with the arrival of innovative biomarkers, like amyloid PET scans, tau imaging, and blood-based mostly tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. While these technological innovations characterize impressive progress in being familiar with neurodegenerative disorders, https://neuropsychologicaltesting67665.csublogs.com/45533144/the-enduring-value-of-cognitive-evaluation-for-older-adults